# Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion

> **NCT07160764** · — · NOT_YET_RECRUITING · sponsor: **Semikal Technology** · enrollment: 80 (estimated)

## Conditions studied

- Intrauterine Abnormalities in Infertility
- Asherman Syndrome
- Intra-uterine Adhesions
- Postoperative Adhesion of Uterus
- Asherman's Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07160764
- **Lead sponsor:** Semikal Technology
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07160764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07160764, "Safety and Performance of the Semical Adhesion Barrier Gel for Prevention of Intra-uterine Adhesion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07160764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*